Navigation Links
IMS in Medical News

US Drug Watchdog Expands Its National Investigation Into The Drug Called Digitek, And Would Like To Talk To Possible Victims

Americas Watchdog's US Drug Watchdog has expanded its national investigation of the drug called Diditek. In April 2008, Actavis Towtowa recalled all lots of Bertek and UDL Laboratories Digitek (digoxin tablets, USP, all strengths) for oral use, due to a manufacturing defect. Since that time ...

Blood Pressure Drug may slow wasting in burn victims

A widely used blood pressure drug shows strong potential for slowing the metabolic overdrive that makes patients waste away after severe burns and other major injuries. In a study, researchers at Shriners Hospital for Children in Galveston, Texas, tried propranolol on 13 children with bad burns and...

Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance

... gross sales to arrive at net sales and the levels of pipeline inventories of our products held by our direct and indirect customers. The Company uses ims Health, Inc. estimates of filled prescriptions for our products as a proxy for market demand. Net sales of our oral contraceptive products inc...

Sagent Pharmaceuticals Announces Launch of First Two Oncolytic Products: Fludarabine Phosphate for Injection, USP and Epirubicin Hydrochloride Injection

...pecialty pharmaceutical company, today announced that it has launched fludarabine phosphate for injection, USP and epirubicin hydrochloride injection. ims data indicates the combined U.S. market for these two products approximated $25 million in 2008. Sagent will begin marketing and shipping both product...

Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009

...d. Risperdal M-TAB had $108.0 million in annual sales in 2008 according to ims Health. Par also launched calcitonin-salmon nasal spray, the gener...S. sales of Miacalcin were approximately $104 million in 2008, according to ims Health. Par currently has approximately 37 ANDAs pending with the FD...

Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG

... XL(R) 25 mg and 50 mg and its generic equivalents had annual sales of approximately $628 million for the twelve months ending June 2009, according to ims sales data. About Watson Pharmaceuticals, Inc. Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharm...

Roxane Laboratories, Inc. Announces the Launch of Risperidone Oral Solution 1mg/mL

...s, on research and development. For more information on Boehringer Ingelheim, please visit http://us.boehringer-ingelheim.com . (1) ims MAT dollar sales ending 3/2009 RISPERDAL(R) is a registered trademark of Ortho-McNeil-Janssen Pharmaceuticals, Inc.. ...

Abilify Has Made Strong Gains in Patient Share Across All Lines of Therapy Since Last Year's Analysis of Prescribing Trends in Schizophrenia

... Insight Series Decision Resources combines in-depth primary research with the most extensive claims-based longitudinal patient-level data from ims Lifelink: Health Plans Claims database to provide exceptional insight into physicians' prescribing trends and the factors that drive therapy product c...

Transcept Pharmaceuticals to Present at BMO Capital Markets Healthcare Conference on August 5, 2009

...Stanford study, fewer than 25 percent of those experiencing middle of the night awakenings reported difficulty going to sleep at bedtime. According to ims Health, the overall U.S. market for prescription sleep aids was approximately $4.0 billion in 2008. Forward Looking Statements Thi...

Mylan Receives FDA Approval for Additional Strengths of the Antipsychotic Haloperidol

...ding March 31 for the same strengths, according to ims Health. Mylan has begun to ship this product. ... $84.7 billion in annual brand sales, according to ims Health. Thirty-five of these pending ANDAs are pot... $16.6 billion in annual brand sales, according to ims Health. Mylan Inc., which provides produc...

More>>

IMS in Medical Technology

Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma

...ge Commission filings, including Item 1A. "Risk Factors" in Schering-Plough's first quarter 2009 10-Q, filed May 1, 2009 References ims Midas data, 2003-2008. "Asthma Facts and Figures." Asthma and Allergy Foundation of America, 2005. Available at: http://www.aafa.org/display....

Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets

...ved from the use of information under license from ims National Prescription Data for the 12 month period ending December 2008. ims expressly reserves all rights, including rights of copying, distribution and republication. ** ims national prescription data from 1992-July 2006. ...

New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development

...armaceutical, biotechnology and medical device industries, and developed by ims Health, the world's leading provider of market intelligence to the pharmace... Notes to editors Survey methodology ICON commissioned ims Health to conduct a survey that explored global trends in drug safety issue...

New Study Showed Lantus(R) Plus One, Two or Three Shots of Apidra(R) Lowered Patients' Blood Sugar

...: SAN) and in New York (NYSE: SNY ). For more information, www.sanofi-aventis.us or www.sanofi-aventis.com * Based on TRx data from ims Health, National Prescription AuditTM (Next Generation Prescription Methodology). Time period: May 2003 to February 2009. (C) 2009 sanofi-aventi...

Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki

...ees with significant experience in anti-infective research and development, who are located in Paris, France and Philadelphia, USA. [1] Source: ims Health, MIDAS, 2006-2008 For further information please contact: Novexel Gordon Waldron, CFO gordon.waldron@novexel.com Citiga...

New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure

...ww.norvasc.com/high-blood-pressure-medicine/about-norvasc.asp . Accessed March 26, 2009. (13) Data are representing May 2002 - February 2006 from ims Health. National Prescription Audit, February 2006. ...

Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line

...ithm Insight Series Decision Resources combines in-depth primary research with the most extensive claims-based longitudinal patient-level data from ims Lifelink: Health Plans Claims database to provide exceptional insight into physicians' prescribing trends and the factors that drive therapy product c...

Teva's Azilect Use Dramatically Increases in Second-Line Therapy for the Treatment of Parkinson's Disease

...thm Insight Series Decision Resources combines in-depth primary research with the most extensive claims-based longitudinal patient-level data from ims Lifelink: Health Plans Claims database to provide exceptional insight into physicians' prescribing trends and the factors that drive therapy product c...

Novexel's NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)

...l's products are targeting the global hospital antibiotic market, which was worth an estimated $15bn in 2007 according to information derived from the ims Midas(R) database. Novexel currently has two novel antibacterials in Phase II clinical development. These are the injectable beta-lactamase inh...

Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)

...d with other symptoms of opiate-induced bowel dysfunction as a result of the opiate binding to the mu-opioid receptor in the gut(1). According to ims Health, about 230 million prescriptions were written for opioids in 2007 in the United States alone. Currently, there are no oral drugs approved tha...
IMS in Medical Dictionary

IM

... financing exports. ... Facts About the Proposed Ex- Im Bank Loans for Petrobras' Brazilian Offshore Oil ... Looking for free web chat? Web-Based ims are gaining in popularity, allowing users access to free web chat with all ... Facebook Chat -- IM and Social ... Chat in MSN®/ Windows Live™ Me...
IMS in Biological Technology

LifeNet Health and IMS Announce Partnership

VIRGINIA BEACH, Va., Nov. 28 /PRNewswire-USNewswire/ -- LifeNet Health, a leading biomedical and allograft agency, announces a strategic partnership with IMS (Integrated Medical Systems International, Inc.), the InstrumentReady(TM) company, to create new software tools for LifeNet Health custo...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

...a(5) n/a(5) (1) Product specific prescription data is provided by ims Health ("IMS") National Prescription Audit, a leading global provider of bu...ng Q2 2009 results using Q2 2008 average foreign exchange rates. (4) ims Data not available. (5) Not sold in the US. Specialty Pharmaceutica...

Digitas Health Expands Adding Two Key Locations

... healthcare communications. www.digitashealth.com | Twitter @Digitas_Health | Facebook: Digitas Health Fan Page (1) ims Dataview, 2007 (2) HM Revenue & Customs , 2007 (3) Milken Institute, The Greater Philadelphia Life Sciences Cluster 2009: An Econom...

Double Helix Strengthens its Strategic Pricing and Reimbursement Practice with Hire of Caryn Zieses

...ers our expanding capabilities." Zieses joins the Double Helix Consulting US team from the Pricing & Reimbursement consulting practice of ims Health. She has worked closely with both large and small pharmaceutical and biotech clients to deliver global strategic recommendations that would in...

Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) Tablets

...c version of Bicalutamide 50 mg tablets is bioequivalent to Casodex(R) which is a registered trademark of AstraZeneca group of companies. According to ims Data, Casodex had US sales of approximately $314 million for the calendar year of 2008. Daniel H. Movens, Caraco's Chief Executive Officer, said...

Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)

...nding March 31 for the same strength, according to ims Health. Mylan has begun to ship this product. ... $82.8 billion in annual brand sales, according to ims Health. Thirty-five of these pending ANDAs are pot... $16.7 billion in annual brand sales, according to ims Health. Mylan Inc., which provides product...

Palkion Selects Novel Oral Development Candidate for the Treatment of Anemia

... of clinical, regulatory and commercial experts from the pharmaceutical industry. There is a great market opportunity for anemia therapeutics as ims Health reported that Erythropoietins such as Aranesp(R), Epogen(R), and Procrit(R), ranked as the #5 top-selling therapeutic classes in the U.S. for 2...

Qforma Appoints Four Executives in Sales and Field Operations

...are industry, with a proven record of exceeding goals and advancing to positions of increasing responsibility at such companies as Tyco International, ims Health, and Concord Management Group. He most recently served as Executive Vice President at Healthy Advice Networks. Dean H. Kleyn brings to his...

Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)

...nding March 31 for the same strength, according to ims Health. This product is indicated for asthma and a... $82.1 billion in annual brand sales, according to ims Health. Thirty-five of these pending ANDAs are pot... $16.7 billion in annual brand sales, according to ims Health. Mylan Inc., which provides products t...

Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD

...n filings, including Part II, Item 1A "Risk Factors" in the Company's first quarter 2009 10-Q, filed May 1, 2009. References: ims Midas data, 2003-2008. The Global Initiative for Asthma: The Global Burden of Asthma Report 2004. World Health Organization. ...

More>>

Other Tags
(Date:9/17/2014)... Asian Americans at higher risk of developing type 2 ... disease at lower body weights? One part of this ... low-fat Asian diets to current westernized diets, which may ... George King, M.D., Senior Vice President and Chief Scientific ... of the study. , A Joslin randomized clinical trial ...
(Date:9/17/2014)... The in vitro diagnostics (IVD) marketplace ... focusing on molecular diagnostics for conditions such as infectious ... The IVD market value is projected to be worth ... The major drivers of the market’s growth include the ... evidenced by the explosion for raid and minimally-invasive diagnostic ...
(Date:9/17/2014)... HealthDay Reporter WEDNESDAY, Sept. 17, 2014 ... explain why antibiotic-resistant bacteria can thrive in a hospital setting. ... be the culprit. They can easily enter bacteria and move ... that makes bacteria drug-resistant, a new study finds. "The ... a class of antibiotic called carbapenems," said the study,s co-author, ...
(Date:9/17/2014)... Research has shown that most 18-month-olds learn an average ... little is known about how children process information to ... years. In a new study, a University of Missouri ... they age, and a limit exists as to how ... could help parents enhance their children,s vocabularies and assist ...
(Date:9/17/2014)... September 17, 2014 Celestix Networks, ... solutions, today announced that it will launch a ... 2014. This new offering will provide seamless Active ... Software-as-a-Service applications to enable secure single sign-on and ... of cloud computing, there has been a dramatic ...
Breaking Medicine News(10 mins):Health News:In Joslin trial, Asian Americans lower insulin resistance on traditional diet 2Health News:In Joslin trial, Asian Americans lower insulin resistance on traditional diet 3Health News:World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com 2Health News:World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com 3Health News:Researchers Discover How Bacteria Resist Antibiotics in Hospitals 2Health News:Researchers Discover How Bacteria Resist Antibiotics in Hospitals 3Health News:Babies learn words differently as they age, researcher finds 2Health News:Celestix Announces Availability of ADFS Bridge Appliance in October 2014 to Simplify the Configuration of Office 365 with Active Directory 2
(Date:9/17/2014)... crime unit designed to fight food fraud in ... being passed off as beef scientists from Germany ... describe their approach, which represents a vast improvement over ... Food Chemistry . , Hans-Ulrich Humpf and colleagues note ... But they also say that adding, for example, horse ...
(Date:9/16/2014)... of severe maternal morbidity amongst women in Australia ... new study published today (17 September) in ... . , Australians generally enjoy high standards of ... disparities exist, in particular between indigenous and non ... explore the independent impact of socioeconomic position on ...
(Date:9/16/2014)... The 36 Pit Fire began on September 13, 2014. ... It is currently over 2,300 acres in size and ... The 36 Pit Fire was calm Monday night due to ... establishing an anchor point and beginning to construct a fireline ... The following resources are working on the fire: , 7 ...
Breaking Biology News(10 mins):New study examines the impact of socioeconomic position & maternal morbidity in Australia 2New study examines the impact of socioeconomic position & maternal morbidity in Australia 3
Other Contents